Individuals with comorbidities in addition to chronic obstructive pulmonary disease (COPD) have an elevated risk of exacerbations, more so if the comorbidity is another chronic respiratory disease, according to a study from the Netherlands.
Findings of two studies presented recently at the European Cancer Congress 2017 (ECCO 2017) demonstrates the effect of the PD-1 inhibitor, pembrolizumab, against a rare form of melanoma and bladder cancer.
The prevalence of benign prostate hypertrophy (BPH) increases with age and is more common in men aged 50 years and above. Dr Ronny Tan, consultant urologist and director of andrology at Tan Tock Seng Hospital, Singapore, speaks on how GPs can best manage this condition.
Uptake of the human papillomavirus (HPV) vaccine is low among vaccine-eligible men in the US, a recent study shows.